Corient Private Wealth LP acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 794,300 shares of the company's stock, valued at approximately $3,670,000. Corient Private Wealth LP owned approximately 0.13% of Medical Properties Trust at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the company. OneAscent Family Office LLC acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $49,000. Greenspring Advisors LLC acquired a new position in Medical Properties Trust during the second quarter valued at approximately $54,000. Callan Family Office LLC purchased a new stake in Medical Properties Trust during the second quarter worth approximately $66,000. Allworth Financial LP purchased a new stake in Medical Properties Trust during the second quarter worth approximately $76,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Medical Properties Trust in the second quarter worth $81,000. Hedge funds and other institutional investors own 71.79% of the company's stock.
Wall Street Analyst Weigh In
Several research firms recently weighed in on MPT. Weiss Ratings lowered shares of Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, August 18th. Royal Bank Of Canada lowered their price target on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a report on Thursday, June 18th. Finally, Wells Fargo & Company cut their price objective on Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating on the stock in a research report on Tuesday. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Sell" and a consensus target price of $4.15.
Read Our Latest Stock Analysis on MPT
Medical Properties Trust Stock Up 1.8%
MPT opened at $4.04 on Wednesday. The stock has a market capitalization of $2.41 billion, a price-to-earnings ratio of -67.33 and a beta of 1.40. The firm's 50 day moving average price is $4.46. Medical Properties Trust, Inc. has a 52-week low of $3.89 and a 52-week high of $6.47. The company has a debt-to-equity ratio of 2.16, a current ratio of 3.12 and a quick ratio of 3.12.
Medical Properties Trust (NYSE:MPT - Get Free Report) last posted its earnings results on Monday, August 10th. The company reported $0.15 EPS for the quarter, hitting analysts' consensus estimates of $0.15. The business had revenue of $259.28 million for the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. Medical Properties Trust's quarterly revenue was up 7.9% compared to the same quarter last year. Equities analysts expect that Medical Properties Trust, Inc. will post 0.6 earnings per share for the current fiscal year.
Medical Properties Trust Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th will be issued a $0.09 dividend. The ex-dividend date is Thursday, September 10th. This represents a $0.36 dividend on an annualized basis and a yield of 8.9%. Medical Properties Trust's payout ratio is currently -600.00%.
About Medical Properties Trust
(
Free Report)
Medical Properties Trust, Inc NYSE: MPT is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.
The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.